Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Ra...
Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced tod...
New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive ...
BTIG analyst Maria Thibault maintains Accuray (NASDAQ:ARAY) with a Buy and raises the price target from $4 to $5.
Accuray (NASDAQ:ARAY) sees FY2026 sales of $471.000 million-$485.000 million vs $454.740 million analyst estimate.
Accuray (NASDAQ:ARAY) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 44...
